ACM
Aisling Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.3M | Buy |
1,316,806
+291,806
| +28% | +$2.73M | 3.43% | 3 |
|
|
2025
Q1 | $12.6M | Hold |
1,025,000
| – | – | 4.36% | 3 |
|
|
2024
Q4 | $13.6M | Hold |
1,025,000
| – | – | 4.81% | 3 |
|
|
2024
Q3 | $19.7M | Hold |
1,025,000
| – | – | 7.56% | 3 |
|
|
2024
Q2 | $21M | Hold |
1,025,000
| – | – | 9.11% | 2 |
|
|
2024
Q1 | $24.4M | Hold |
1,025,000
| – | – | 8.26% | 2 |
|
|
2023
Q4 | $22.2M | Hold |
1,025,000
| – | – | 6.61% | 3 |
|
|
2023
Q3 | $14.9M | Hold |
1,025,000
| – | – | 6.13% | 3 |
|
|
2023
Q2 | $21.5M | Hold |
1,025,000
| – | – | 10.51% | 3 |
|
|
2023
Q1 | $21.6M | Hold |
1,025,000
| – | – | 10.42% | 4 |
|
|
2022
Q4 | $26.1M | Hold |
1,025,000
| – | – | 17.22% | 3 |
|
|
2022
Q3 | $24.6M | Hold |
1,025,000
| – | – | 16.36% | 2 |
|
|
2022
Q2 | $19.7M | Hold |
1,025,000
| – | – | 14.07% | 2 |
|
|
2022
Q1 | $17.8M | Hold |
1,025,000
| – | – | 9.61% | 3 |
|
|
2021
Q4 | $22.4M | Hold |
1,025,000
| – | – | 7.92% | 3 |
|
|
2021
Q3 | $19.6M | Hold |
1,025,000
| – | – | 3.91% | 6 |
|
|
2021
Q2 | $17.6M | Hold |
1,025,000
| – | – | 2.82% | 6 |
|
|
2021
Q1 | $22.9M | Hold |
1,025,000
| – | – | 4.13% | 4 |
|
|
2020
Q4 | $22.8M | Hold |
1,025,000
| – | – | 3.91% | 5 |
|
|
2020
Q3 | $15.1M | Hold |
1,025,000
| – | – | 4.83% | 4 |
|
|
2020
Q2 | $15.2M | Buy |
1,025,000
+150,000
| +17% | +$2.22M | 5.8% | 5 |
|
|
2020
Q1 | $9.6M | Buy |
+875,000
| New | +$9.6M | 4.18% | 4 |
|